ReNerve Limited (ASX:RNV)
Australia · Delayed Price · Currency is AUD
0.0900
+0.0010 (1.12%)
At close: Mar 26, 2026
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
|---|
Medical Devices For Damaged Peripheral Nerves | 271.71K | 177.37K | 128.49K |
Medical Devices For Damaged Peripheral Nerves Growth | 53.18% | 38.04% | - |
| 271.71K | 177.37K | 128.49K |
| 53.18% | 38.04% | - |
Revenue by Geography
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
|---|
| 738.00 | 789.00 | - |
| -6.46% | - | - |
| 267.87K | 176.58K | - |
| 51.70% | - | - |
| 3.10K | - | - |
| - | - | 128.49K |
| 271.71K | 177.37K | 128.49K |
| 53.18% | 38.04% | - |
Source: S&P Global Market Intelligence.